Mexico will participate in clinical trials within Phase 3 of the HIV vaccine
Grow Your Business, Not Your Inbox
Mexico will participate with 150 volunteers for Phase 3 of what could be the vaccine against the Human Immunodeficiency Virus (HIV) that the Belgian pharmaceutical company Janssen is developing.
On December 2, it was when the news of a possible vaccine against HIV was announced that finally reached Phase 3 in clinical trials. The international project called ' Mosaic' has begun the process of recruiting volunteers who will participate in this study, which aims to search for effectiveness in the vaccine.
- Maybe you're interested: The 19-year-old who wants to end pancreatic cancer
According to the EFE agency, there are eight countries that will test the efficacy of this vaccine against the AIDS virus and Mexico is there, among the participating health institutions in the Aztec country are: the Institute of Medical Sciences and Nutrition "Salvador Zubirán" , the Condesa Iztapalapa Specialized Clinic, the Benjamín Sepúlveda Amor Clinic in Mexico City, the Guadalajara Civil Hospital and the Mérida Medical Care and Health Research Unit.
Countries that will have volunteers for the vaccine
Among the countries that will participate with volunteers for the vaccine will be Mexico, Argentina, Brazil, Italy, Peru, Poland, Spain and the United States. The research aims to enroll 3,800 people worldwide.
The participation of 150 Mexicans
Andrea González, director of the Center for the Prevention and Comprehensive Care of HIV / AIDS in Mexico City, who is in charge of the application of the vaccine, indicated that in her center they proposed to recruit 150 volunteers.
Taking into account the above, the study participants must undergo surveillance for a minimum of 12 months, in which they will have to attend the clinic an average of 14 times and receive a total of six injections during the entire study, according to information from the official website.
Through social networks, the process has begun to get volunteers to participate in this trial.